Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research Trials [0.03%]
第二届HIV研究试验分析治疗中断专家共识研讨会推荐意见
Thumbi Ndung&#x;u,Krista L Dong,Donn J Colby et al.
Thumbi Ndung&#x;u et al.
Analytical treatment interruption (ATI) is an important tool to evaluate interventions designed to achieve HIV eradication or long-term control without antiretroviral therapy. We convened a stakeholder workshop to update the published recom...
Silvia Maria da Silva Sant&#x;Ana Rodrigues,Lucindo José Quintans-Júnior,Adriano Antunes de Souza Araújo et al.
Silvia Maria da Silva Sant&#x;Ana Rodrigues et al.
Racial, ethnic, and regional disparities in HIV testing during the COVID-19 pandemic in the USA: a nationwide, retrospective, observational study using National Clinical Cohort Collaborative data [0.03%]
在美国，COVID-19大流行期间HIV检测的种族、族裔和地区差异：一项使用全国临床队列协作数据进行的全国性回顾性观察研究
Haishan Yang,Duolan Han,Eric Hurwitz et al.
Haishan Yang et al.
Background: The COVID-19 pandemic caused major disruptions to health care, affecting the delivery of HIV care and prevention services. We aimed to determine the impact of the pandemic on HIV testing rates in medical setti...
Thomas J O&#x;Grady,James M Tesoriero
Thomas J O&#x;Grady
Graeme Meintjes,Gary Maartens
Graeme Meintjes
Same-day versus rapid ART initiation in people with HIV and symptoms of tuberculosis (SaDAPT): a randomised, non-inferiority trial in Lesotho and Malawi [0.03%]
在莱索托和马拉维开展的一次随机、非劣效性试验：HIV合并结核症状患者的同日与快速启动抗逆转录病毒治疗（SaDAPT）
Felix Gerber,Robina Semphere,Blaise Lukau et al.
Felix Gerber et al.
Background: Whether same-day antiretroviral therapy (ART) should be offered to people with HIV with tuberculosis symptoms or whether ART should be initiated only after tuberculosis diagnostic results are available is unkn...
Safety and immunogenicity of a single dose of Ad26.COV2.S, BNT162b2, or SARS-CoV-2-rS-protein-nanoparticle in previously vaccinated and unvaccinated adults living with and without HIV in South Africa: a phase 2a randomised, observer-blind trial [0.03%]
在南非开展的单次接种腺病毒载体疫苗Ad26.COV2.S、mRNA疫苗BNT162b2或SARS-CoV-2-rS蛋白纳米颗粒疫苗（针对新冠疫苗接种史不同且有无HIV感染情况）人群中的安全性与免疫原性IIa期随机观察盲临床试验
Vaneshree Govender,Tarylee Reddy,Pholo Maenetje et al.
Vaneshree Govender et al.
Background: WHO recommends a boost COVID-19 vaccine dose for people with immunosuppression, including people living with HIV. Data from randomised controlled trials assessing approaches to homologous and heterologous COVI...
Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial [0.03%]
多国开放标签III期b阶段随机对照试验：二
Felix G Mhlanga,Daniel W Szydlo,Ashley J Mayo et al.
Felix G Mhlanga et al.
Background: Pregnant women are at a four times higher risk of HIV per coital act than non-pregnant women. MTN-042/DELIVER was a phase 3b randomised study of dapivirine vaginal ring (DVR) and oral pre-exposure prophylaxis ...
Rubeshan Perumal,Kogieleum Naidoo
Rubeshan Perumal
Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial [0.03%]
住院成人患者隐球菌性脑膜炎和HIV晚期疾病的一月异烟肼和利福平结核病预防治疗（IMPROVE）：非劣效性随机对照试验
Jayne Ellis,Gila Hale,Laura J Nsangi et al.
Jayne Ellis et al.
Background: Tuberculosis preventive therapy coverage for people with advanced HIV disease (AHD) is poor. Innovative delivery strategies to increase tuberculosis preventive therapy uptake are needed; we sought to evaluate ...